It is required that the documented comprehensive assessment includes a drug profile that contains the patient's current prescription and over-the-counter (OTC) drugs. The medication review process includes the identification of the following: the effectiveness of drug therapy; actual or potential drug interactions. The drug profile is updated per the hospice policy and procedure, but, at minimum, at the time of each comprehensive assessment and/or when new medication is added or changes are made to existing medication. This standard was not met as evidenced by a review of clinical records and interview. 2 of 11 (18%) records reviewed revealed that drug profiles were incomplete or not updated. Record #6 was reviewed and identified the patient elected hospice care on 06/18/2022. The initial assessment completed by the registered nurse (RN) on 06/18/2022 documented that the patient was on Oxygen at 2 liters per minute per nasal cannula. Oxygen was not listed on the medication profile. Record #10 was reviewed and identified the patient elected hospice care on 06/19/2022. The initial assessment completed by the registered nurse (RN) on 06/19/2022 documented that the patient was on Oxygen at 2 liters per minute per nasal cannula. Oxygen was not listed on the medication profile. The Director of Nursing was interviewed on 07/13/22 and confirmed that oxygen should have been added to the medication profiles.
Every finding on record at Caring Hospice II LLC
Missouri City, Texas · CCN 971514
1 finding across 1 survey, in the inspector's own words.
The inspector’s own words from form CMS-2567, unedited, including CMS’s own spacing. Names and some dates are redacted by CMS.
Survey of July 13, 2022
1 finding← Back to the Caring Hospice II LLC record
Federal survey findings only. State licensure findings for hospices are not shown.
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction